May 4, 2023
Moderna Reports Drop in Revenue, Driven by Lower COVID-19 Vaccine Sales
Moderna reported a decline in revenue in the first quarter of 2023 due to lower sales of its COVID-19 vaccines. Moderna made $1.9 billion in revenue in the first quarter of 2023, down 68 percent from the first quarter of 2022. ...
NEXT EPISODE
PREVIOUS EPISODE